Dokument: Prospektive Erhebung des Zeitaufwandes für Selbstmanagement im Zusammenhang mit Diabetes anhand eines generischen Tagebuchs
| Titel: | Prospektive Erhebung des Zeitaufwandes für Selbstmanagement im Zusammenhang mit Diabetes anhand eines generischen Tagebuchs | |||||||
| Weiterer Titel: | Measuring the time cost of diabetes | |||||||
| URL für Lesezeichen: | https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=61232 | |||||||
| URN (NBN): | urn:nbn:de:hbz:061-20221123-100020-0 | |||||||
| Kollektion: | Dissertationen | |||||||
| Sprache: | Deutsch | |||||||
| Dokumententyp: | Wissenschaftliche Abschlussarbeiten » Dissertation | |||||||
| Medientyp: | Text | |||||||
| Autor: | Mallmann, Florian Peter [Autor] | |||||||
| Dateien: |
| |||||||
| Beitragende: | Prof. Dr. med. Dr. PH Andrea Icks [Gutachter] Prof. Dr. med. Stefan Wilm [Gutachter] | |||||||
| Dewey Dezimal-Klassifikation: | 600 Technik, Medizin, angewandte Wissenschaften » 610 Medizin und Gesundheit | |||||||
| Beschreibungen: | Ca. 9% der über 18-jährigen Weltbevölkerung leiden unter der Erkrankung Diabetes
mellitus. Diese hohe Prävalenz geht mit einer hohen Krankheitslast für das Gesundheitssystem einher. Die Zeit, welche die PatientInnen im Alltag für das Selbstmanagement ihrer Erkrankung brauchen, wurde in der Vergangenheit bereits in einigen Studien untersucht. Diesen ist gemeinsam, dass der Zeitaufwand für spezifische diabetesrelevante Aktivitäten retrospektiv erhoben wurde. Die Ergebnisse dieser Studien variieren zwischen 19 Minuten und 2-3 Stunden pro Tag. Ziel dieser Arbeit ist es, die Durchführbarkeit der prospektiven Zeiterhebung für diabetesrelevante Aktivitäten anhand eines generischen Tagebuches zu untersuchen. Dafür wurde die Methode der Zeitverwendungserhebung des Statistischen Bundesamtes verwendet. Die Teilnehmenden erhielten ein Tagebuch, das sie an drei hintereinander folgenden Tagen führen sollten. Dieses teilte den Tag tabellarisch in Zeiteinheiten von zehn Minuten auf. Zur Auswertung wurde die Kodierung der Zeitverwendungserhebung des Statistischen Bundesamtes genutzt und um diabetesrelevante Aktivitätencodes erweitert. Zusätzlich wurde ein Fragebogen zu Angaben wie Alter, Geschlecht, Beruf, sozioökonomischem Status und Gesundheitsangaben ausgehändigt. 19 von 25 angesprochenen Teilnehmenden führten das Tagebuch. Die Teilnehmenden hatten ein Durchschnittsalter von 61 Jahren. 17 der 19 eingereichten Tagebücher enthielten diabetesrelevante Aktivitäten. Die Ergebnisse zeigen einen durchschnittlichen täglichen Zeitaufwand von 63,9 Minuten für diabetesrelevante Aktivitäten. Alle Teilnehmenden gaben Insulininjektionen als Teil ihrer Therapie an, nur 8 dokumentierten auch einen Zeitaufwand für diese Aktivität. Die Messung des Blutzuckers wurde von 11 der 19 Teilnehmenden protokolliert und führte zu einem durchschnittlichen Zeitaufwand von 27 Minuten pro Tag. Frauen investierten ca. 50% mehr Zeit im Vergleich zu Männern in das Diabetes-Selbstmanagement, wobei die HbA1c-Werte beider Geschlechter sich nicht signifikant unterschieden. Die qualitative Analyse der Kommentare der Teilnehmenden zeigt, dass die Einteilung in 10- Minuten-Einheiten für die Dokumentation von Aktivitäten wie bspw. Blutzuckermessung zu lang ist. Zusammengefasst zeigen die Ergebnisse, dass die angewandte prospektive Erhebungsmethode den Zeitaufwand für viele diabetesrelevante Aktivitäten messen kann. Das Zeitintervall von zehn Minuten kann jedoch zu einer Fehleinschätzung des Zeitaufwands führen. Insgesamt können aus den Ergebnissen dieser Studie wichtige Erkenntnisse abgeleitet werden, die zu Verbesserungen für zukünftige Zeiterhebungen führen.About 9 % of the global population over 18 years suffer from diabetes mellitus. These figures illustrate the relevance of this disease for the health care system. The time required by patients to self-treat diabetes mellitus has already been investigated in several studies. These have in common that they asked for specific activities related to the disease and measured the time spent on diabetes retrospectively. The results of these studies vary considerably, ranging from 19 minutes to 2-3 hours per day. In this study we use a prospective design to examine, whether patients document the diabetes-related activities and how much time they invested into these activities without being asked for specific activities and their time requirements. A diary to protocol three days was given out to the patients. It divides each of the three days into units of ten minutes. In every unit the participants had to write down the performed activities. A questionnaire was given out to collect information regarding age, sex, employment-status, socioeconomic-status and health-status. 19 of 25 patients completed and returned the logbook. The participants had an average age of 61 years, 11 were employed and 8 retired. 17 of the 19 returned diaries contained diabetes-related activities. The results indicate an average time-use of 63,9 min/day for diabetes related activities. Although all participants used insulin-application for diabetes-treatment, only 8 documented the time used for this activity. Monitoring of blood-glucose was documented by 11 of the 19 patients with an average time expenditure of 27 min per day. A comparison between female and male participants shows, that although women invest approx. 50% more time in treating the disease, the HbA1c-values do not differ significantly. A qualitative analysis of the individual comments by the participants revealed, that units of ten minutes are too long to document the regular diabetes-related activities like insulin-application or bloodglucose monitoring. In summary, the results proof that the method in its implemented form can measure the time required for diabetes-related activities. The interval of ten minutes used for the diary turned out to be too long, as proofed by the participant’s comments. Though, usage of 10- minutes-intervals may also result in an overestimation of the time cost. However, based on this study, proposals for the optimization of future studies could be derived. | |||||||
| Quelle: | IDF Atlas 9th edition and other resources; 2020.
https://www.diabetesatlas.org/en/resources/ (accessed 26. Juni 2020). 2. American Diabetes Association. 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2020. Diabetes care 2020;43:S7-S13. 3. Kochanek KD, Murphy SL, Xu JQ, Arias E. Deaths: Final data for 2017. National Vital Statistics Reports 2019;68. 4. Jacobs E, Hoyer A, Brinks R, Kuss O, Rathmann W. Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data From 65 Million People in Germany. Diabetes care 2017;40:1703–1709. 5. Köster I, Schubert I, Huppertz E. Fortschreibung der KoDiM-Studie: Kosten des Diabetes mellitus 2000-2009. Deutsche medizinische Wochenschrift (1946) 2012;137:1013–1016. 6. Jacobs E, Hoyer A, Brinks R, Icks A, Kuß O, Rathmann W. Healthcare costs of Type 2 diabetes in Germany. Diabetic medicine : a journal of the British Diabetic Association 2017;34:855–861. 7. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA 2002;288:2469–2475. 8. Grady PA, Gough LL. Self-management: a comprehensive approach to management of chronic conditions. American journal of public health 2014;104:e25-31. 9. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Education and Counseling 2002;48:177–187. 10. Chernyak N, Jülich F, Kasperidus J, Stephan A, Begun A, Kaltheuner M, et al. Time cost of diabetes: Development of a questionnaire to assess time spent on diabetes self-care. Journal of Diabetes and its Complications 2017;31:260–266. 11. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-Management Education for Adults With Type 2 Diabetes. Diabetes care 2002;25:1159–1171. 77 12. Yen LE, McRae IS, Jowsey T, Bagheri N. Time spent on health related activity by older Australians with diabetes. Journal of diabetes and metabolic disorders 2013;12:33. 13. Ettner SL, Cadwell BL, Russell LB, Brown A, Karter AJ, Safford M, et al. Investing time in health: do socioeconomically disadvantaged patients spend more or less extra time on diabetes self-care? Health Econ. 2009;18:645–663. 14. Safford MM, Russell L, Suh D-C, Roman S, Pogach L. How Much Time Do Patients with Diabetes Spend on Self-Care? The Journal of the American Board of Family Medicine 2005;18:262–270. 15. Icks A, Haastert B, Arend W, Konein J, Thorand B, Holle R, et al. Time spent on self-management by people with diabetes: results from the population-based KORA survey in Germany. Diabetic medicine : a journal of the British Diabetic Association 2019;36:970–981. 16. Russell LB, Suh D-C, Safford MA. Time requirements for diabetes selfmanagement: too much for many? The Journal of family practice 2005;54:52–56. 17. Juster FT, Stafford FP. The Allocation of Time: Empirical Findings, Behavioral Models, and Problems of Measurement. Journal of Economic Literature 1991;29:471–522. 18. Bauman A, Bittman M, Gershuny J. A short history of time use research; implications for public health. BMC public health 2019;19:1–7. 19. Statistisches Bundesamt. Wie die Zeit vergeht: Ergebnisse zur Zeitverwendung in Deutschland 2012/2013;2015:1–30. 20. Poretsky L. Diabetes Mellitus A Concise clinical Guide. New York: Springer; 2012. 21. National Diabetes Data Group. Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance. Diabetes 1979;28:1039–1057. 22. American Diabetes Association. Classification and Diagnosis of Diabetes Sec. 2. Diabetes care 2017;40:S11-S24. 23. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes care 2020;43:S14-S31. 78 24. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010;464:1293–1300. 25. Leslie RD, Palmer J, Schloot NC, Lernmark A. Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment. Diabetologia 2016;59:13–20. 26. Kerner W, Brückel J. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes 2014;122:384–386. 27. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. The Lancet 2011;378:169–181. 28. Liu LL, Yi JP, Beyer J, Mayer-Davis EJ, Dolan LM, Dabelea DM, et al. Type 1 and Type 2 diabetes in Asian and Pacific Islander U.S. youth: the SEARCH for Diabetes in Youth Study. Diabetes care 2009;32 Suppl 2:S133-40. 29. Fazeli Farsani S, van der Aa MP, van der Vorst MMJ, Knibbe CAJ, Boer A de. Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia 2013;56:1471–1488. 30. Riemer-Kafka G. Versicherungsmedizinische Gutachten: Ein interdisziplinärer juristisch-medizinischer Leitfaden. Basel: Schwabe Verlag Basel; 2017. 31. Scholtens DM, Kuang A, Lowe LP, Hamilton J, Lawrence JM, Lebenthal Y, et al. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism. Diabetes care 2019;42:381–392. 32. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W. Cystic Fibrosis– Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality. Diabetes care 2009;32:1626–1631. 33. Hecking M, Werzowa J, Haidinger M, Hörl WH, Pascual J, Budde K, et al. Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrology, dialysis, transplantation 2013;28:550–566. 34. Kamrath C, Mönkemöller K, Biester T, Rohrer TR, Warncke K, Hammersen J, et al. Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany. JAMA 2020;324:801–804. 79 35. Herold G (ed). Innere Medizin 2015. Köln: Selbstverl.; 2015. 36. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of Diabetes and Diabetes-Related Complications. Physical therapy 2008;88. 37. Tuttolomondo A, Maida C, Pinto A. Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients. Journal of diabetes research 2015. 38. American Diabetes Association. 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2020. Diabetes care 2020;43:S48-S65. 39. Funnell MM, Anderson RM. The problem with compliance in diabetes. JAMA 2000;284:1709. 40. American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2020. Diabetes care 2020;43:S66-S76. 41. American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes care 2020;43:S98-S110. 42. Lachin M. Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population. Diabetes care 2016;39:1378–1383. 43. Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C, et al. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2020;63:221–228. 44. Tönnies T, Röckl S, Hoyer A, Heidemann C, Baumert J, Du Y, et al. Projected number of people with diagnosed Type 2 diabetes in Germany in 2040. Diabetic medicine : a journal of the British Diabetic Association 2019;36:1217–1225. 45. Heidemann C, Du Y, Schubert I, Rathmann W, Scheidt-Nave C. Prävalenz und zeitliche Entwicklung des bekannten Diabetes mellitus. Bundesgesundheitsblatt 2013;56:668–677. 46. Tamayo T, Brinks R, Hoyer A, Kuß OS, Rathmann W. The Prevalence and Incidence of Diabetes in Germany. Deutsches Arzteblatt international 2016;113:177–182. 80 47. Magliano DJ, Islam RM, Barr ELM, Gregg EW, Pavkov ME, Harding JL, et al. Trends in incidence of total or type 2 diabetes: systematic review. BMJ (Clinical research ed.) 2019;366:l5003. 48. American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2017. Diabetes care 2018;41:917–928. 49. Ulrich S, Holle R, Wacker M, Stark R, Icks A, Thorand B, et al. Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies. BMJ Open 2016;6:e012527. 50. Kähm K, Laxy M, Schneider U, Rogowski WH, Lhachimi SK, Holle R. Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany. Diabetes care 2018;41:971–978. 51. Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Bärnighausen T, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-ofillness study. Essays on health and development 2018:25–38. 52. Seuring T, Archangelidi O, Suhrcke M. The Economic Costs of Type 2 Diabetes: A Global Systematic Review. PharmacoEconomics 2015;33:811–831. 53. Dowrick C, Dixon-Woods M, Holman H, Weinman J. What is chronic illness? Chronic Illness 2005;1:1–6. 54. Clark NM, Becker MH, Janz NK, Lorig K, Rakowski W, Anderson L. Self- Management of Chronic Disease by Older Adults. J Aging Health 1991;3:3–27. 55. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health affairs (Project Hope) 2001;20:64–78. 56. Barlow JH, Sturt J, Hearnshaw H. Self-management interventions for people with chronic conditions in primary care: Examples from arthritis, asthma and diabetes. Health Education Journal 2002;61:365–378. 57. Swendeman D, Ingram BL, Rotheram-Borus MJ. Common elements in selfmanagement of HIV and other chronic illnesses: an integrative framework. AIDS care 2009;21:1321–1334. 81 58. Nakagawa-Kogan H, Garber A, Jarrett M, Egan KJ, Hendershot S. Selfmanagement of hypertension: predictors of success in diastolic blood pressure reduction. Research in nursing & health 1988;11:105–115. 59. Barlow J. How to use education as an intervention in osteoarthritis. Best practice & research. Clinical rheumatology 2001;15:545–558. 60. Corbin J, Strauss A. Managing chronic illness at home: Three lines of work. Qual Sociol 1985;8:224–247. 61. Lorig KR, Holman HR. Self-management education: History, definition, outcomes, and mechanisms. Ann Behav Med 2003;26:1–7. 62. Haas L, Maryniuk M, Beck J, Cox CE, Duker P, Edwards L, et al. National standards for diabetes self-management education and support. The Diabetes educator 2012;38:619–629. 63. Mazzuca SA, Moorman NH, Wheeler ML, Norton JA, Fineberg NS, Vinicor F, et al. The diabetes education study: a controlled trial of the effects of diabetes patient education. Diabetes care 1986;9:1–10. 64. Gary TL, Genkinger JM, Guallar E, Peyrot M, Brancati FL. Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. The Diabetes educator 2003;29:488–501. 65. Deakin T, McShane CE, Cade JE, Williams RDRR. Group based training for selfmanagement strategies in people with type 2 diabetes mellitus. The Cochrane database of systematic reviews 2005:CD003417. 66. Funnell M, Jongen P, Lorig K, Ritter PL, Turner RM, English K, et al. Benefits of Diabetes Self-Management for Health Plan Members: A 6-Month Translation Study. Journal of medical Internet research 2016;18. 67. Jowsey T, Yen L, W PM. Time spent on health related activities associated with chronic illness: a scoping literature review. BMC public health 2012;12:1044. 68. Russell LB. Completing costs: patients' time. Medical care 2009;47:S89-93. 69. Russell LB, Safford MM. The importance of recognizing patients' time as a cost of self-management. The American journal of managed care 2008;14:395–396. 82 70. Funnell MM, Anderson RM. The Problem With Compliance in Diabetes. JAMA 2000;284:1709. 71. Lauterbach K, Stock S, Brunner H (eds). Gesundheitsökonomie: Lehrbuch für Mediziner und andere Gesundheitsberufe. Lehrbuch Gesundheitswissenschaften. Bern: Huber; 2009. 72. Icks A, Claessen H, Strassburger K, Waldeyer R, Chernyak N, Jülich F, et al. Patient time costs attributable to healthcare use in diabetes: results from the population-based KORA survey in Germany. Diabet. Med. 2013;30:1245–1249. 73. Sonnenberg B, Riediger M, Wrzus C, Wagner GG. Measuring Time Use in Surveys – How valid are time use questions in surveys? Concordance of survey and experience sampling measures. Soc Sci Res 2012;41:1037–1052. 74. Minnen J, Glorieux I, van Tienoven TP, Daniels S, Weenas D, Deyaert J, et al. Modular Online Time Use Survey (MOTUS) – Translating an existing method in the 21 st century. eIJTUR 2014;11:73–93. 75. Kan, MY, Pudney S. Measurement Error in Stylized and Diary Data on Time Use. Sociological Methodology 2008;38:101–132. 76. Kitterød RH, Lyngstad TH. Diary versus questionnaire information on time spent on housework – The case of Norway. electronic International Journal of Time Use Research 2005;2:13–32. 77. Riediger M RA. Experience Sampling in Lifespan Developmental Methodology. Oxford Research Encyclopedia of Psychology;2018. 78. Yen L, McRae IS, Jowsey T, Gillespie J, Dugdale P, Banfield M, et al. Health work by older people with chronic illness: how much time does it take? Chronic Illness 2013;9:268–282. 79. Kamble S, Weinfurt KP, Schulman KA, Reed SD. Patient Time Costs Associated with Sensor-Augmented Insulin Pump Therapy for Type 1 Diabetes. Med Decis Making 2013;33:215–224. 80. Maier L. Methodik und Durchführung der Zeitverwendungserhebung 2012/2013. WISTA – Wirtschaft und Statistik;2014:672–679. 83 81. Chatzitheochari S, Fisher K, Gilbert E, Calderwood L, Huskinson T,Cleary A, et al. Using New Technologies for Time Diary Data Collection: Instrument Design and Data Quality Findings from a Mixed-Mode Pilot Survey. Soc Indic Res 2018;137:379–390. 82. Fitzgerald JT, Anderson RM, Davis WK. Gender Differences in Diabetes Attitudes and Adherence. The Diabetes educator 1995;21:523–529. 83. Verbrugge. Sex differentials in health. Public Health Rep 1982;97:417. 84. Kandrack M-A, Grant KR, Segall A. Gender differences in health related behaviour: Some unanswered questions. Social Science & Medicine 1991;32:579– 590. 85. Hibbard JH, Pope CR. Gender roles, illness orientation and use of medical services. Social Science & Medicine 1983;17:129–137. 86. McEwen LN, Kim C, Ettner SL, Herman WH, Karter AJ, Beckles GL, Brown AF. Competing Demands for Time and Self-Care Behaviors, Processes of Care, and Intermediate Outcomes Among People With Diabetes. Diabetes care 2011;34:1180–1182. 87. Gallant MP. The influence of social support on chronic illness self-management: a review and directions for research. Health education & behavior 2003;30:170–195. 88. Whittemore R, D'Eramo MG, Grey M. Metabolic control, self-management and psychosocial adjustment in women with type 2 diabetes. Journal of clinical nursing 2005;14. 89. Miller TA, DiMatteo MR. Importance of family/social support and impact on adherence to diabetic therapy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013;6:421–426. 90. Tang TS, Brown MB, Funnell MM, Anderson RM. Social support, quality of life, and self-care behaviors among African Americans with type 2 diabetes. The Diabetes educator 2008;34:266–276. 91. Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Education and Counseling 2016;99:926–943. 84 92. Jutterström L, Hörnsten Å, Sandström H, Stenlund H, Isaksson U. Nurse-led patient-centered self-management support improves HbA1c in patients with type 2 diabetes-A randomized study. Patient Education and Counseling 2016;99:1821– 1829. 93. Azami G, Soh KL, Sazlina SG, Salmiah MS, Aazami S, Mozafari M, et al. Effect of a Nurse-Led Diabetes Self-Management Education Program on Glycosylated Hemoglobin among Adults with Type 2 Diabetes. Journal of diabetes research 2018;2018:4930157. 94. Pani LN, Nathan DM, Grant RW. Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%. Diabetes care 2008;31:386–390. 95. Sloan FA, Padrón NA, Platt AC. Preferences, beliefs, and self-management of diabetes. Health services research 2009;44:1068–1087. 96. Heckman JJ. Selection Bias and Self-selection. In: Eatwell J, Milgate M, Newman PK (eds). Econometrics. The New Palgrave. London: Macmillian reference books; 1990:201–224. 97. Hendriks M, Ludwigs K, Veenhoven R. Why are Locals Happier than Internal Migrants? The Role of Daily Life. Soc Indic Res 2016;125:481–508. 98. Fernee, H, Sonck, N. Measuring smarter: Time use data collected by smartphones. eIJTUR 2014;11:94–96. 99. Fisher K, Chatzitheochari S, Gilbert E, Calderwood L. A Mixed-mode Approach to Measuring Young People's Time Use in the Millennium Cohort Study. electronic International Journal of Time Use Research 2015:174–180. 100. Steinert A, Haesner M, Steinhagen-Thiessen E. App-basiertes Selbstmonitoring bei Typ-2-Diabetes. Zeitschrift fur Gerontologie und Geriatrie 2017;50:516–523. | |||||||
| Lizenz: |  Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz | |||||||
| Bezug: | 2017-2022 | |||||||
| Fachbereich / Einrichtung: | Medizinische Fakultät | |||||||
| Dokument erstellt am: | 23.11.2022 | |||||||
| Dateien geändert am: | 23.11.2022 | |||||||
| Promotionsantrag am: | 10.03.2022 | |||||||
| Datum der Promotion: | 15.11.2022 |
